カテゴリ： GlobalData, アメリカ, 企業調査

Exosome Diagnostics Inc：企業の製品パイプライン分析2018

◆英語タイトル：Exosome Diagnostics Inc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C2778
◆発行会社（調査会社）：GlobalData
◆発行日：2018年8月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer’s disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exosome Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Exosome Diagnostics Inc Company Overview 5
Exosome Diagnostics Inc Company Snapshot 5
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Exosome Diagnostics Inc – Pipeline Analysis Overview 7
Exosome Diagnostics Inc – Key Facts 7
Exosome Diagnostics Inc – Major Products and Services 8
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Pipeline Products Overview 13
Biofluid Nucleic Acid Kit – Alzheimer’s Disease 13
Biofluid Nucleic Acid Kit – Alzheimer’s Disease Product Overview 13
Biofluid Nucleic Acid Kit – Cardiovascular Disease 14
Biofluid Nucleic Acid Kit – Cardiovascular Disease Product Overview 14
Biofluid Nucleic Acid Kit – Chronic Kidney Disease 15
Biofluid Nucleic Acid Kit – Chronic Kidney Disease Product Overview 15
Biofluid Nucleic Acid Kit – Parkinson’s Disease 16
Biofluid Nucleic Acid Kit – Parkinson’s Disease Product Overview 16
Biofluid-Based Molecular Diagnostic Test – Brain Cancer 17
Biofluid-Based Molecular Diagnostic Test – Brain Cancer Product Overview 17
BIONIC Liquid Biopsy – Bladder Cancer 18
BIONIC Liquid Biopsy – Bladder Cancer Product Overview 18
Diagnostic Test – Neurodegenerative Diseases 19
Diagnostic Test – Neurodegenerative Diseases Product Overview 19
EXO1000 20
EXO1000 Product Overview 20
ExoDx Lung(EGFR) 21
ExoDx Lung(EGFR) Product Overview 21
ExoDx Lung(EGFR) Clinical Trial 22
ExoDx Lung(T790M) 23
ExoDx Lung(T790M) Product Overview 23
ExoDx Prostate(IntelliScore) – IVD Version 24
ExoDx Prostate(IntelliScore) – IVD Version Product Overview 24
ExoDx Prostate(IntelliScore) – IVD Version Clinical Trial 25
Next-Generation Solid Tumor Mutation Panel 26
Next-Generation Solid Tumor Mutation Panel Product Overview 26
Shahky 27
Shahky Product Overview 27
Exosome Diagnostics Inc – Key Competitors 28
Exosome Diagnostics Inc – Key Employees 29
Exosome Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Exosome Diagnostics Inc, Recent Developments 31
Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification 31
May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel 31
May 17, 2018: Exosome Diagnostics’ Second Prospective Validation Study of EPI to be Highlighted at American Urological Association (AUA) Annual Meeting Press Briefing in San Francisco, CA 32
May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain 33
May 09, 2018: Exosome Diagnostics Continues to Expand Coverage Reach for its EPI Test 33
May 08, 2018: Exosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate(IntelliScore) (EPI) Test 34
Apr 17, 2018: Exosome Diagnostics Obviates Tissue Biopsies 34
Mar 21, 2018: Exosome Diagnostics Names Grannum Sant As Head Of Medical Affairs 35
Feb 23, 2018: Exosome Diagnostics Expands its Coverage Reach for EPI to an Additional 82 Million Covered Lives in the United States 36
Feb 23, 2018: NIH Launches International Study of AMD Progression 36
Appendix 38
Methodology 38
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Exosome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Indication 6
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 6
Exosome Diagnostics Inc, Key Facts 7
Exosome Diagnostics Inc, Major Products and Services 8
Exosome Diagnostics Inc Number of Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Pipeline Products Summary by Development Stage 10
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Exosome Diagnostics Inc Ongoing Clinical Trials Summary 12
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Status 13
Biofluid Nucleic Acid Kit - Alzheimer's Disease - Product Description 13
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Status 14
Biofluid Nucleic Acid Kit - Cardiovascular Disease - Product Description 14
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Status 15
Biofluid Nucleic Acid Kit - Chronic Kidney Disease - Product Description 15
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Status 16
Biofluid Nucleic Acid Kit - Parkinson's Disease - Product Description 16
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Status 17
Biofluid-Based Molecular Diagnostic Test - Brain Cancer - Product Description 17
BIONIC Liquid Biopsy - Bladder Cancer - Product Status 18
BIONIC Liquid Biopsy - Bladder Cancer - Product Description 18
Diagnostic Test - Neurodegenerative Diseases - Product Status 19
Diagnostic Test - Neurodegenerative Diseases - Product Description 19
EXO1000 - Product Status 20
EXO1000 - Product Description 20
ExoDx Lung(EGFR) - Product Status 21
ExoDx Lung(EGFR) - Product Description 21
ExoDx Lung(EGFR) - A Phase I/II, Open-label, Safety, Pharmacokinetic and Preliminary Efficacy Study of Oral Rociletinib in Patients with Previously Treated Mutant EGFR Non-small Cell Lung Cancer (NSCLC) 22
ExoDx Lung(T790M) - Product Status 23
ExoDx Lung(T790M) - Product Description 23
ExoDx Prostate(IntelliScore) - IVD Version - Product Status 24
ExoDx Prostate(IntelliScore) - IVD Version - Product Description 24
ExoDx Prostate(IntelliScore) - IVD Version - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study including Impact on Decision-making and Health Economics 25
Next-Generation Solid Tumor Mutation Panel - Product Status 26
Next-Generation Solid Tumor Mutation Panel - Product Description 26
Shahky - Product Status 27
Shahky - Product Description 27
Exosome Diagnostics Inc, Key Employees 29
Exosome Diagnostics Inc, Subsidiaries 30
Glossary 40

List of Figures
Exosome Diagnostics Inc Pipeline Products by Equipment Type 6
Exosome Diagnostics Inc Pipeline Products by Development Stage 9
Exosome Diagnostics Inc Ongoing Clinical Trials by Trial Status 11

★海外企業調査レポート[Exosome Diagnostics Inc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • AAC Technologies Holdings Inc. (2018)：企業の財務・戦略的SWOT分析
    AAC Technologies Holdings Inc. (2018) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Coca-Cola Icecek A.S.：企業の戦略・SWOT・財務情報
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Northstar Electronics, Inc.：企業の戦略・SWOT・財務分析
    Northstar Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Environmental Container Systems Inc：企業の戦略・SWOT・財務情報
    Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report Summary Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • CytImmune Sciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies. The company develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Its Aurimune binds TNF receptors on blood vessel cells at the …
  • Westell Technologies Inc (WSTL)：企業の財務・戦略的SWOT分析
    Summary Westell Technologies Inc (Westell) is a communication service company that provides wireless infrastructure solutions. The company offers in-building wireless, intelligent site management and communication network solutions. The company’sin-building wireless include antennas, distributed ant …
  • Institut Curie-製薬・医療分野：企業M&A・提携分析
    Summary Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biolog …
  • Japan Display Inc：企業の戦略・SWOT・財務情報
    Japan Display Inc - Strategy, SWOT and Corporate Finance Report Summary Japan Display Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Metro AG：戦略・SWOT・企業財務分析
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Imdex Limited (IMD)-石油・ガス分野：企業M&A・提携分析
    Summary Imdex Limited (Imdex) is a provider of integrated technological solutions to the mineral industry. The company offers drilling fluids, drilling equipment, advanced downhole instrumentation, data management solution and analytical software for geological modeling through its AMC and REFLEX br …
  • EA Pharma Co Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Lakeview Hotel Investment Corp.：戦略・SWOT・企業財務分析
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Divi’s Laboratories Ltd (DIVISLAB)：企業の財務・戦略的SWOT分析
    Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • SS&C Technologies Holdings Inc.：企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • GS Yuasa Corporation (6674)：企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mattel, Inc.：企業の戦略・SWOT・財務情報
    Mattel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mattel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • University of Strathclyde：製薬・医療：M&Aディール及び事業提携情報
    Summary University of Strathclyde (Strathclyde) is an educational service provider that offers education, learning technologies and facilities. The university offers a wide range of undergraduate and postgraduate programs, and distance learning programs through its faculties of engineering, science, …
  • Amcor Ltd：企業のM&A・事業提携・投資動向
    Amcor Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amcor Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Advaxis Inc (ADXS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm …
  • Medison Pharma Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆